SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Natco Pharma informs about board meeting

29 Jan 2018 Evaluate

Natco Pharma has informed that that the meeting of the board of directors of the Company is scheduled to be held on February 06, 2018, to consider the unaudited financial Results for the quarter and nine months ended December 31, 2017 (Q3) and related matters; and to consider Second Interim Dividend, if any, for the financial year 2017-18 and related matters etc. Further, pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 trading window for dealing in the securities of the Company will be closed from January 29, 2018 to February 08, 2018.Trading window will be opened from February 09, 2018.

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

1118.95 31.25 (2.87%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×